Global Pharmaceutical Industry Isolator and Containment System Market Research Report 2022

SKU ID : QYR-21196796 | Publishing Date : 01-Jul-2022

The pharmaceutical isolator is a bacteriologically sealed enclosure used in the medical and pharmaceutical environment for toxic processes and aseptic filling process. Isolators are a core component to the pharmaceutical industry, critical for a range of processes. These gas-tight enclosures provide a complete barrier to ensure aseptic conditions and containment. Many R&D or production processes handle highly active pharmaceutical compounds, very toxic chemicals, or Nano sized material, which have the possibility of causing harmful effects on the human body and surrounding environment. To reduce exposure risk by scattering hazardous or toxic materials, a handling facility or system are required to be placed in an isolated area and operators are required to put on Personal Protective Equipment (PPE), dust masks, gloves and suits. In such cases the work environment becomes poor, and operators are still exposed to the hazardous surroundings. Introduction of isolators or glove boxes into such processes enables perfect containment of hazardous and toxic materials and keeps the scattering risk to operators and the environment at a minimum level, thus resulting in prevention of contamination of the product and improvement of the working environment and reduction of overall cost of the facility and its management.
Due to the COVID-19 pandemic, the global Pharmaceutical Industry Isolator and Containment System market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Pharmaceutical Industry Isolator and Containment System market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Pharmaceutical Industry Isolator and Containment System landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Sterility Test Isolator accounting for % of the Pharmaceutical Industry Isolator and Containment System global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Pharmaceutical Industry segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Pharmaceutical Industry Isolator and Containment System include Getinge, Steriline, Fedegari, Extract Technology, Syntegon, Comecer, Carlo Erba Reagents, Bioquell and Azbil Telstar, etc. In terms of revenue, the global 3 largest players have a % market share of Pharmaceutical Industry Isolator and Containment System in 2021.
This report focuses on Pharmaceutical Industry Isolator and Containment System volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Pharmaceutical Industry Isolator and Containment System market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Pharmaceutical Industry Isolator and Containment System Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Sterility Test Isolator
Sterility Production Isolator
Segment by Application
Pharmaceutical Industry
Hospital
Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Getinge
Steriline
Fedegari
Extract Technology
Syntegon
Comecer
Carlo Erba Reagents
Bioquell
Azbil Telstar
ITECO Engineering
Hosokawa Micron
TAILIN Bioengineering
Tofflon
Tema Sinergie
F.P.S.
ISOTECH
Weike
Weiler Engineering

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
market Reports market Reports